# Atorvastatin Versus Rosuvastatin on Contrast Induced Acute Kidney Injury (PRATO-ACS 2)

> **NCT01870804** · PHASE4 · COMPLETED · sponsor: **Centro Cardiopatici Toscani** · enrollment: 760 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Rosuvastatin
- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT01870804
- **Lead sponsor:** Centro Cardiopatici Toscani
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2016-07
- **Final completion:** 2016-09
- **Target enrollment:** 760 (ACTUAL)
- **Last updated:** 2016-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01870804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01870804, "Atorvastatin Versus Rosuvastatin on Contrast Induced Acute Kidney Injury (PRATO-ACS 2)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01870804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*